🇺🇸

Corporate Governance

US SEC Filing Intelligence · 451 digests

New to these filings? Learn what a DEF 14A proxy statement is

· daily

US Executive Compensation Proxy SEC Filings — October 09, 2026

This digest covers 22 DEF 14A and DEFM14A filings for the 'Executive Compensation Insights' stream, centered on annual proxy statements, governance, and shareholder proposals. The filings are dominated by routine governance mechanics (director elections, auditor ratification, say-on-pay votes), with very few supplied with quantitative period-over-period financial data. The most substantive financial disclosures come from Coherent Corp. (record FY2026 revenue of $7.12B, up 22.5% YoY, GAAP gross margin up 233 bps to 37.5%), Sezzle (2025 net income $133.1M, up 70% YoY), and Performance Food Group (qualitative growth claims with no specific figures). The highest-materiality situations are corporate-action votes rather than compensation items: XWELL's airport-business sale with an unquantified arbitration exposure, and Newbury Street II's SPAC extension where post-redemption trust balances may fall far below the ~$186.9M held. Shareholder-dilution and capital-structure proposals (Envirotech's reverse split and preferred conversion, International Battery Metals' up-to-1-for-50 consolidation, Solidion's 975,000-share plan increase) cluster as a theme. Executive compensation disclosure is largely absent from the excerpts, which limits direct pay analysis and insider-activity signals. Overall, the stream's information content is thin, so the most actionable items are the time-sensitive votes and redemption deadlines.

22 high priority 22 total filings
· daily

US Executive Officer Management Changes SEC — October 09, 2026

The 33 filings in this stream are almost entirely Item 5.02 officer and director changes dated October 9, 2026, with no quantitative period-over-period financial data disclosed in any filing. Themes are clustered around CFO and finance-leadership turnover (Quantum, Standard Motor Products, Phoenix Education Partners, NextBoat, Bark's principal accounting officer), commercial and revenue leadership exits (Jazz, HealthEquity, Mitek, Veea, Myriad, Vogenx's conversion to CCO), and a wave of independent director appointments with strong operating or audit backgrounds (Cisco, Enerpac, Gen Digital, TOP Financial, Goldenwell). The most market-relevant developments are governance stress at Sidus Space (two director resignations citing governance disagreements, with the company disputing the characterizations), Quantum's CFO termination paired with a guidance-meeting expectation during an early close, and Quince/IRulya's CEO and COO turnover coinciding with a ticker change and pre-revenue pipeline readouts. Most other filings are neutral routine transitions, and the stream's most important near-term events are scheduled earnings and corporate actions (MSG spin-off record date October 20, Standard Motor Products and Avient Q3 reports, Quince's conversion and renaming on October 9 and 12).

33 high priority 33 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 09, 2026

This board-room digest covers 33 SEC 8-K filings dated around October 9, 2026, all centred on officer and director changes rather than operating results. Nearly every filing is sentiment-neutral and explicitly disclaims any disagreement with management, which is the dominant pattern in the sample. The more consequential developments cluster around finance leadership: CFO exits or interim CFO appointments at Quantum, Phoenix Education Partners, Standard Motor Products, and Off the Hook/NextBoat, plus a PAO departure at BARK. Governance stress is most visible at Sidus Space, where two directors resigned citing governance and oversight disagreements, and at Quantum, where a CFO was terminated alongside an upbeat guidance statement. No filing in this set reports period-over-period financial figures, insider transactions, or capital allocation changes, so quantitative trend analysis is not possible from the enriched fields provided; the signals below rely on qualitative and governance data.

33 high priority 33 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 08, 2026

This digest covers nine DEF 14A and DEFM14A filings dated around October 8, 2026, under a stream focused on executive compensation, governance, and shareholder proposals. The filings are dominated by annual meeting notices with proxy proposals (director elections, auditor ratification, say-on-pay, and equity plan changes), so most period-over-period financial comparisons are unavailable in the supplied excerpts. The clearest quantitative compensation trend comes from Leatt Corp, where CEO compensation actually paid rose from $231,762 in 2024 to $623,512 in 2025 (+169%), and average non-PEO NEO pay rose from $433,799 to $746,443 (+72%). AngioDynamics reported FY2026 GAAP revenue growth of 9.5%, with Med Tech up 18.4% and Med Device up only 2.6%, while its equity plan amendment seeks more shares. The most material development is the proposed merger of Cherry Hill Mortgage into TPG Mortgage Investment Trust, though the excerpt lacks deal terms. Governance themes include widespread use of equity plan share increases (Leatt, AngioDynamics, Palomino), reverse-split and blocker-driven ownership opacity (Jaguar Health), and interested-trustee structures (Robinhood Ventures Fund I). Several filings (Siebert, BGC) provided little legible content beyond headers and XBRL tags, which limits assessment.

9 high priority 9 total filings
· daily

US Executive Officer Management Changes SEC — October 08, 2026

This batch of 23 Officer and Director change filings (all dated October 8, 2026 window) is dominated by governance housekeeping, planned succession, and a handful of distressed or governance-stressed situations. Of the 23 filings, roughly 9 carry explicit succession or appointment content with forward-dated effective dates (General Dynamics, MFA Financial, Byline Bancorp, Henry Schein, OGE Energy, Vontier, Gartner, Kirby, Avalon GloboCare), while the rest are routine director resignations or retirements with no-disagreement language. No period-over-period financial metrics were disclosed in any filing, so trend analysis must rely on qualitative signals rather than YoY or QoQ figures. The most market-relevant items are the Lifeward CFO reversal (negative, interim leadership with no permanent CFO), the KonaTel sole-director board (governance concern), and the Avalon GloboCare interim CEO vacancy tied to a drone-defense acquisition pivot. On the positive side, eXp World/AGNT's CEO succession from a founder to an operator with a recent acquisition track record and RB Global's guidance reaffirmation to the high end stand out. Overall the stream signals a cluster of CFO and CLO turnover, which is worth monitoring for execution risk during reorganizations.

23 high priority 23 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 08, 2026

This board-room digest covers 23 SEC 8-K filings dated around October 8, 2026, of which 22 fall within the Officer Change, Director Change, and Board Change scope; one filing (Byline-adjacent scope is retained, but Montrose/Onterris is retained as a director change) — in practice all 23 are governance events, so none are excluded. The dominant theme is leadership succession and planned transitions: General Dynamics' CEO handover (Danny Deep to CEO effective January 1, 2027, with Phebe Novakovic moving to executive chairman after serving since 2013), MFA Financial's CEO succession (Bryan Wulfsohn to CEO July 1, 2027), OGE Energy's COO elevation, and Byline Bancorp's commercial-banking reshuffle. A second cluster is CFO and legal-officer churn: Henry Schein is replacing its CFO after 18 years with incoming CFO Emmanuel Caprais, Gartner's Chief Legal Officer departs October 16, and Lifeward's CFO appointment collapsed before start. Several smaller-cap names show governance stress, most notably KonaTel (board cut to a single director who is also CEO and Chairman) and Avalon GloboCare (interim CEO resigned to pursue a drone-defense acquisition). Period-over-period financial metrics were not disclosed in most of these governance filings, so the analysis relies on qualitative and event-driven signals rather than YoY or QoQ trend data. Market implication: planned, internally driven successions (GD, MFA, OGE, RB Global) are generally low-risk, while unplanned departures at micro-caps and unexplained interim roles warrant closer scrutiny.

23 high priority 23 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 07, 2026

The seven proxy filings reveal a polarized landscape in executive compensation and governance. Flexible Solutions and CISO Global show contrasting pay-performance alignment: Flexible cut CEO pay 30% despite TSR improvement but net income collapsed 74%, while CISO awarded 311% pay increases to executives who subsequently resigned. M&A activity dominates high-materiality filings: Centerspace's fixed-exchange merger with IRT and Charlton Aria's SPAC combination with KQC Quantum both carry significant execution and valuation risks. Onconetix continues its struggle with Nasdaq compliance, seeking a third reverse split in two years amid heavy dilution from PIPE and equity line transactions. In contrast, Clorox and SLR Investment present routine governance updates with strong insider ownership and enhanced risk oversight, offering stability. Overall, the stream highlights a divergence between companies using equity to retain talent versus those facing shareholder dilution and leadership churn.

7 high priority 7 total filings
· daily

US Executive Officer Management Changes SEC — October 07, 2026

The October 7, 2026 executive and director change filings reveal a wave of leadership transitions across US-listed companies, with notable activity in the technology and industrial sectors. Key themes include a significant number of CFO changes (BiomX, FuelCell Energy, Nukkleus, Advasa, Alkami, Matternet) and board refreshments (Crane NXT, WillScot, BCB Bancorp, TE Connectivity, Nutanix). Several transitions are tied to major corporate actions, such as Corteva's spin-off of Vylor Inc. and Boston Scientific's segment reorganization, which signal strategic pivots. Compensation packages for new executives are substantial, indicating competitive talent markets, particularly in tech and healthcare. While most transitions are orderly, BiomX's going concern qualification and CEO compensation structure, along with Matternet's CFO departure and option extension, warrant close monitoring. Overall, the period reflects a healthy churn in leadership, with a mix of routine governance updates and strategic appointments that could impact company performance and investor sentiment.

17 high priority 17 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 07, 2026

The October 7, 2026, board room change filings reveal a significant wave of corporate restructuring and leadership transitions across the US market, with a notable concentration in the industrial and technology sectors. The most critical development is Corteva's successful spin-off of its seed business into Vylor Inc., a major strategic move that triggered a complete board and C-suite overhaul, representing the highest materiality event in this batch. A clear pattern of orderly CFO transitions is evident, with FuelCell Energy, Alkami Technology, and Advasa Holdings all announcing CFO changes with structured transition periods, suggesting proactive succession planning rather than crisis-driven departures. The data also shows a trend of appointing directors with deep operational and regulatory expertise, such as Dr. Jeong H. Kim at Crane NXT (former Bell Labs President) and Donald Slager at WillScot (former Republic Services CEO), signaling a focus on governance strengthening. While no period-over-period financial comparisons were available in these specific filings, the forward-looking data on executive compensation packages (e.g., Hims & Hers' $3M RSU grant to new CAO) and separation agreements (e.g., Matternet's $156K CFO severance) provide actionable intelligence on company financial health and talent retention strategies. The mixed sentiment at BiomX/Tessera, with its going concern qualification and performance-based CEO equity awards, represents the highest-risk situation requiring immediate investor attention.

17 high priority 17 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 06, 2026

This digest of 13 proxy filings reveals a bifurcated market where high-growth AI and defense-linked companies are delivering record financials and rewarding shareholders, while SPACs and early-stage biotechs face existential risks. Key period-over-period trends include Sandisk's staggering 175% YoY revenue surge to $20.25B and Lumentum's Q4 revenue doubling to over $1B, both driven by AI infrastructure demand. Conversely, K&F Growth Acquisition Corp. II is on the brink of forced liquidation if a merger extension is not approved, highlighting the ongoing SPAC winter. Insider activity is limited in these filings, but capital allocation signals are strong, with Sandisk achieving a zero-debt balance sheet and Pro-Dex executing a strategic acquisition. The most critical development is the potential liquidation of K&F Growth, which could trigger a $308M trust distribution, while the positive momentum in Sandisk and Lumentum presents clear opportunities for investors seeking exposure to the AI hardware theme. Overall, the filings suggest a 'haves and have-nots' dynamic, with capital flowing to proven AI winners and away from speculative vehicles.

13 high priority 13 total filings
· daily

US Executive Officer Management Changes SEC — October 06, 2026

This intelligence stream covering October 6, 2026, reveals a bifurcated landscape in US executive and director changes. While the majority of filings (32 of 40) reflect routine succession planning, internal promotions, and board refreshment, a cluster of high-materiality events signals significant corporate stress and strategic pivots. The most critical developments include a boardroom coup at **Better Home & Finance Holding Co** (BETRW), where founder Vishal Garg ousted five directors and the interim CEO, leaving the company leaderless; a strategic retreat by **Caribou Biosciences** (CRBU), which is discontinuing its lead CAR-T programs and exploring a sale after burning through cash; and a transformative financing at **Accuray Inc** (ARAY), which secured a debt-for-equity swap and a reverse stock split to stave off financial distress. On the positive side, high-profile board appointments at **Paramount Skydance Corp** (SKYD) and **Tenable Holdings** (TENB) signal strategic depth ahead of major catalysts. Period-over-period trends are limited as most filings lack financial data, but the insider activity and capital allocation signals are stark: a clear pattern of founder-led consolidation of control at BETRW, and a sector-wide shift away from risky allogeneic CAR-T development at CRBU. The overall tone is cautiously neutral, with pockets of both acute distress and strategic opportunity.

40 high priority 40 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 06, 2026

This digest of 40 SEC filings reveals a boardroom landscape dominated by routine succession planning and governance adjustments, punctuated by several high-stakes corporate control events. The most critical development is the hostile boardroom coup at Better Home & Finance, where founder Vishal Garg successfully removed five directors and the interim CEO, creating significant governance uncertainty. In contrast, Stryker's planned CEO succession from Kevin Lobo to Spencer Stiles represents a textbook example of long-term leadership planning. A notable sector theme is the infusion of high-profile technology and media expertise into boards, with Paramount Skydance appointing Robert Kotick and Laurene Powell Jobs ahead of its WBD merger, and Tenable adding former AWS/Microsoft executive Charlie Bell. Financially stressed companies like Accuray and Caribou Biosciences are undergoing board changes concurrent with restructuring—Accuray securing a financing deal with TCW while implementing a reverse stock split, and Caribou exploring strategic alternatives after discontinuing its CAR-T programs. The overall sentiment across filings is neutral, but the presence of multiple high-materiality events (Better Home, Accuray, Caribou) signals elevated governance risk in the small-cap and micro-cap space.

40 high priority 40 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 05, 2026

This digest of 15 proxy filings reveals a market sharply bifurcated between companies pursuing transformative M&A and those fighting for survival. A dominant theme is the surge in SPAC and de-SPAC activity, with Bold Eagle, Melar, and Bowman Consulting all seeking shareholder approval for business combinations or take-private deals, indicating a busy Q4 2026 for event-driven investors. Conversely, several micro-cap companies like XMax, Silexion Therapeutics, and Innovative Eyewear are in acute distress, seeking shareholder approval for massive dilutive financings and reverse stock splits to stave off Nasdaq delisting, creating significant risks for existing holders. Western Digital stands out as a relative bright spot, citing strong revenue growth and margin expansion from AI-driven demand, while Flex Ltd. navigates a complex spin-off and acquisition. Insider trading activity is notably absent from these filings, but forward-looking statements and capital allocation decisions—from stock splits at Seneca Foods to a critical advisory agreement change at Elevation Series Trust—provide actionable catalysts. The overall sentiment is mixed, with a clear divide between companies with strategic clarity and those in reactive, survival mode.

15 high priority 15 total filings
· daily

US Executive Officer Management Changes SEC — October 05, 2026

This batch of 32 filings covering officer and director changes reveals a period of significant leadership transition across US-listed companies, with notable patterns in CFO turnover, insider retention, and strategic board appointments. Period-over-period comparisons from enriched data show mixed financial health: Insmed reiterated $1.25B-$1.40B revenue guidance for BRINSUPRI while NeoGenomics reported preliminary Q3 revenue of ~$209M with NGS growth of ~28% YoY, and Neighborhood Intelligence (formerly Bed Bath & Beyond) achieved over $50M in SG&A reductions year-to-date. Critical developments include Pinterest's appointment of an Amazon veteran as CFO, Chevron's internal CFO succession as part of a broader leadership reshuffle, and Aterian's going-concern qualification from its former auditor. Insider activity is limited but significant: Boost Run granted ~$76.4M in aggregate RSUs to three top executives, and Silver Bow Mining granted change-of-control-triggered RSUs to its CEO. Forward-looking data points to several catalysts: PMV Pharma's planned NDA submission in Q1 2027, WEBTOON's Marvel app launch on November 16, 2026, and NeoGenomics' CEO succession on January 4, 2027. Portfolio-level themes include a wave of CFO departures (Insmed, OFA Group, Bunge, Pinterest, Neighborhood Intelligence), strategic board appointments bringing semiconductor and Web3/AI expertise, and a clear pattern of retention-focused equity grants post-transaction or during turnaround phases.

32 high priority 32 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 05, 2026

The 32 filings reveal a wave of C-suite and board-level transitions across US-listed companies, with notable clusters in the energy, technology, and healthcare sectors. Key themes include strategic CFO successions at Pinterest, Insmed, and Neighborhood Intelligence, often tied to growth or turnaround phases, and a trend of appointing directors with specialized expertise (semiconductors, public safety, Web3/AI). Forward-looking data highlights several catalysts, including NeoGenomics' preliminary Q3 revenue beat and guidance raise, PMV Pharma's Q1 2027 NDA submission, and WEBTOON's Marvel app launch. Risk flags include Aterian's going-concern qualification and auditor dismissal, and the lack of disclosure in Awaysis Capital's officer change filing. Insider activity is limited but includes significant retention-based RSU grants at Boost Run and Curaleaf, and a CEO board appointment at Lion Copper & Gold. Overall, the period-over-period data shows a mix of growth (NeoGenomics NGS +28% YoY) and operational challenges (Neighborhood Intelligence SG&A reductions), with capital allocation focused on executive retention and strategic hires.

32 high priority 32 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 02, 2026

The 21 filings in this executive compensation digest reveal a period of significant corporate restructuring and shareholder value events. A dominant theme is the wave of M&A and liquidation proposals, with Utz Brands, MarineMax, and Steele Creek Capital all seeking shareholder approval for going-private or dissolution transactions, signaling a potential peak in private equity interest and a lack of confidence in public market valuations. Governance is under the spotlight, with Fermi Inc. terminating its CEO for cause and Oaktree Acquisition Corp. III Life Sciences and Chain Bridge I seeking repeated extensions, highlighting execution risks in the SPAC space. Financially, Adtalem Global Education stands out with strong 9.3% revenue growth and 23.7% adjusted EPS growth, while Jack Henry & Associates shows steady performance with 22 consecutive years of dividend increases. However, the Tax-Free Fixed Income Funds for Puerto Rico Residents are liquidating due to high expense ratios and governance disputes, underscoring the challenges in closed-end fund structures. Overall, the period is characterized by a mix of value realization events and governance red flags, with a clear trend toward consolidation and capital return to shareholders.

21 high priority 21 total filings
· daily

US Executive Officer Management Changes SEC — October 02, 2026

This digest covers 43 executive and director change filings from October 2, 2026, revealing a period of significant leadership turnover across sectors. A dominant theme is planned succession and board restructuring, with several companies (Seritage, Aimco, Nocopi) implementing transition periods and consulting arrangements to ensure continuity. Notably, compensation adjustments are prevalent, with Starfighters Space approving a 224% CEO salary increase and Live Nation extending its CEO's contract through 2031 with a $40M annual equity grant, signaling strong retention efforts. Board shakeups are material at Hub Group (three directors removed by stockholder consent) and Quince Therapeutics (three directors conditionally resigning). The data also shows a clear trend of companies appointing directors with specific expertise, such as mineral exploration at Klotho Neurosciences and former UK PM Liz Truss at RTB Digital, indicating strategic pivots. Overall, while most filings are neutral in sentiment, the high volume of changes suggests a dynamic corporate governance landscape with potential for both disruption and strategic realignment.

43 high priority 43 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 02, 2026

This batch of 43 filings reveals a significant wave of board and C-suite changes across US-listed companies, with a notable concentration of planned successions and departures effective October 1, 2026. A key theme is the prevalence of 'neutral' sentiment filings, indicating routine transitions rather than performance-driven upheaval, though several high-materiality events stand out. The most impactful developments include a major board shakeup at Hub Group (materiality 7/10) driven by stockholder action, a leadership transition at Hines Global Income Trust (materiality 6/10) signaling a generational shift, and the appointment of a former UK Prime Minister to the board of RTB Digital (materiality 3/10). While enriched data on period-over-period financial trends is largely absent from these filings, the insider activity and forward-looking statements provide actionable intelligence, particularly around the CEO extension at Live Nation (materiality 6/10) and the commercial-stage transition at Celcuity (materiality 6/10). The overall pattern suggests a period of governance recalibration, with several companies strengthening independent board representation and aligning executive compensation with performance metrics.

43 high priority 43 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 01, 2026

This batch of 12 DEF 14A filings, primarily from small-cap and micro-cap companies, paints a picture of a market segment heavily focused on internal governance, equity incentive management, and capital structure adjustments. A dominant theme is the use of shareholder meetings to authorize share increases for equity plans (Akari Therapeutics, Modular Medical) and warrant exercises (HCW Biologics), signaling a reliance on equity-based compensation and financing. The four Lightstone REITs present a highly unusual pattern of back-to-back meetings on the same day, all with near-identical director election proposals, suggesting centralized governance but raising concerns about shareholder oversight. ResMed stands as a clear outlier, showcasing strong operational performance (8% revenue growth, 17% EPS growth, $1.6B FCF) and significant capital return ($1B+ in dividends/buybacks, up >70% YoY), contrasting sharply with the capital-constrained nature of the other filers. Sysco provided a positive tone on AI/tech transformation, but lacked specific financial data. The overall sentiment is neutral-to-cautious, with the primary actionable intelligence centered on ResMed’s strength and the risk of dilution at several smaller firms.

12 high priority 12 total filings
· daily

US Executive Officer Management Changes SEC — October 01, 2026

This digest synthesizes 44 enriched SEC filings (Oct 1, 2026) covering US executive and director changes. Key themes include a wave of CEO/CFO successions (e.g., First Merchants, American Vanguard), aggressive board refreshment with tech/AI expertise (Leidos, Omega Healthcare), and governance actions with significant dilution (Aclarion 10x share increase). Notable capital allocation includes a $250M buyback at Choice Hotels and a $1B+ special dividend at Leidos. Risks center on insider selling (Mattel CEO), rising leverage (Omega), and governance overhang (Aclarion). Opportunities emerge from new leadership with strong operational track records and strategic pivots toward high-growth sectors.

44 high priority 44 total filings